This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
The Role of Concentrated Insulins in Overcoming Insulin Resistance and Improving Adherence: A Patient-Centered, Multidisciplinary Approach

The Role of Concentrated Insulins in Overcoming Insulin Resistance and Improving Adherence: A Patient-Centered, Multidisciplinary Approach

Format

Roundtable

Time to Complete

2 hours

Released

December 28, 2017

Expires

December 28, 2018
Add to Queue


Maximum Credits

2.00 / AMA PRA Category 1 CreditsTM
2.00 / CE for Nurses

Accredited Provider

This activity is jointly provided by Global Education Group and Physicians' Education Resource®, LLC (PER®).

Commercial Supporter

This activity is supported independent educational grants from Novo Nordisk, Inc and Sanofi US.

Program Description

During this Medical Crossfire, expert faculty will engage in a multidisciplinary roundtable discussion that includes an endocrinologist, a certified diabetes educator, an endocrinology NP and a patient to discuss how to best optimize and individualize insulin therapy. In patients with insulin-resistant diabetes who have requirements of more than 200 units/day or 100 units/injection, novel concentrated insulins provide the same or better glucose control compared to older insulins, with fewer daily injections and reduced injection volume. However, safe use requires an experienced physician, a motivated and cooperative patient, and a dynamic diabetes management team. This program will provide practical strategies that can be implemented to improve quality of care with a focus on how an interdisciplinary team can help support the patient.

Intended Audience

This educational series is designed for endocrinologists, certified diabetes educators, nurse practitioners, physician assistants and other health care professionals with an interest in insulin therapy.

Educational Objectives

After completing this activity, clinicians should be better able to:
  • IDENTIFY patients with T2DM who may benefit from the addition of insulin to their management strategy
  • LIST patient/practitioner barriers toward insulin that impact patient adherence
  • ARTICULATE the role of diabetes team members in implementing DMSE/S algorithm of care
  • EVALUATE the pharmacologic features of concentrated insulin formulations
  • PROPOSE an individualized treatment strategy utilizing a collaborative team-based approach to patient care that safely appropriately and effectively transition patients to concentrated insulin

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations

Faculty

Chair/Moderator:
Mark E. Molitch, MD

Martha Leland Sherwin Professor of Endocrinology,
Division of Endocrinology, Metabolism and Molecular Medicine
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Dr. Molitch discloses the following:
Grants/Research Support – Bayer, Calibria, Chiasma, Novartis, Novo Nordisk
Consultant - Chiasma, Novartis, Janssen

Davida F. Kruger, MSN, APN-BC,BC-ADM
Certified Nurse Practitioner
Supervisor Nurse Practitioner
Henry Ford Health System
Division of Endocrinology, Diabetes and Bone Disorders
Detroit, Michigan

Ms. Kruger discloses the following:
Advisory Board – Abbott, Dexicom, Eli Lily, Intarcia, Janssen, Novo Nordisk, Sanofi US
Grants/Research Support - Astra Zeneca, Dexcom, Eli Lilly, Hemsley Foundation, Lexicon
Speaker’s Bureau – Abbott, Astra Zeneca, Boehringer Ingelheim, Dexcom, Janssen, Eli Lilly, Novo Nordisk, Valeritas
Stock – Dexcom

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
Director, Riverside Diabetes Center
Riverside Medical Associates
Riverdale, Maryland
Adjunct Assistant Professor, Graduate School of Nursing
Uniformed Services University of the Health Sciences
Bethesda, Maryland

Ms. Novak discloses the following:
Advisory Board – Sanofi US
Consultant – CeQur, Intarcia
Speaker’s Bureau - Astra Zeneca, Janssen, Novo Nordisk

Russell Davis, Patient

Accredited Provider Disclosure

Global Education Group
Planning StaffAshley Marostica, RN, MSN; Lindsay Borvansky; Kristen Delisi, NP; Andrea Funk; and Liddy Knight have no relevant financial relationships with commercial interests to disclose

Publishing Staff Disclosures

Physicians’ Education Resources
Planning StaffDavid Heckard; Maryjo Dixon, RPh; Dipti Desai, PharmD, RPh; and Katie Pierson have no relevant financial relationships with commercial interests to disclose

Credit

2.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physicians’ Education Resource®, LLC (PER®). Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this live activity for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

2.00

Type

CE for Nurse Practitioners

Accreditation Statement


This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Physicians’ Education Resource®, LLC. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024.

Designation Statement

This activity is approved for 2.00 contact hour(s) which includes 0.00 hour(s) of pharmacology.

Activity ID # 2463E

This activity was planned in accordance with AANP CE Standards and Policies.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Global Education Group or Physicians’ Education Resource, LLC. This material is prepared based on a review of multiple sources of information, but it is not exhaustive of the subject matter.

Therefore, health care professionals and other individuals should review and consider other publications and materials on the subject.

Instructions

In order to receive credit, participants must complete the pre-assessment questions, view the activity in its entirety, and complete the post-test and program evaluation. Participants must also score at least 70% on the post-test. You will receive a digital copy of your credit certificate at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

There is no fee for this educational activity.

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue